Role of F-18 FDG PET/CT in Predicting Response to Neoadjuvant Chemotherapy in Invasive Ductal Breast Cancer.

Autor: Sengoz T; Department of Nuclear Medicine, Pamukkale University Faculty of Medicine, Denizli, Turkey., Arman Karakaya Y; Department of Pathology, Pamukkale University Faculty of Medicine, Denizli, Turkey., Gültekin A; Department of Nuclear Medicine, Pamukkale University Faculty of Medicine, Denizli, Turkey., Yilmaz S; Department of General Surgery, Pamukkale University Faculty of Medicine, Denizli, Turkey., Erdem E; Department of General Surgery, Pamukkale University Faculty of Medicine, Denizli, Turkey., Yapar Taskoylu B; Department of Medical Oncology, Pamukkale University Faculty of Medicine, Denizli, Turkey., Kesen Z; Kesen Pathology Laboratory, Denizli, Turkey., Yaylali O; Department of Nuclear Medicine, Pamukkale University Faculty of Medicine, Denizli, Turkey., Yuksel D; Department of Nuclear Medicine, Pamukkale University Faculty of Medicine, Denizli, Turkey.

Publikováno v: European journal of breast health [Eur J Breast Health] 2023 Apr 01; Vol. 19 (2), pp. 159-165. Date of Electronic Publication: 2023 Apr 01 (Print Publication: 2023).

Detection of deleted in malignant brain tumors 1 and runt-related

Autor: Dodurga, Y, Avci, CB, Satiroglu-Tufan, NL, Tataroglu, C, Kesen, Z, Dogan, ZO, Yilmaz, S, Gunduz, C

Bladder cancer is the fifth most commonly diagnosed cancer in the United States, where the majority of tumors are transitional cell carcinoma. Deleted in malignant brain tumors 1 (DMBT1) gene is located at chromosome 10q25.3-q26.1. DMBT1 gene express

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::817cdb6f15b312a688688356fc2851dd
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/20972

Evaluation of deleted in malignant brain tumors 1 (DMBT1) gene

Autor: Dodurga, Y, Avci, CB, Yilmaz, S, Dogan, ZO, Kesen, Z, Tataroglu, C, Satiroglu-Tufan, NL, Bushra, T, Gunduz, C

This study was undertaken to evaluate the expression of DMBT1 in bladder cancer and its correlation with clinicopathological parameters analyzed in bladder carcinoma patients. We investigated DMBT1 in 56 paraffin embedded specimens of transitional ce

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::76255024efa7724daa4dddf3565a7894
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/13236

Evaluation of deleted in malignant brain tumors 1 (DMBT1) gene expression in bladder carcinoma cases: preliminary study

Autor: Dodurga Y, Avci CB, Yilmaz S, Dogan ZO, Kesen Z, Tataroglu C, Satiroglu-Tufan NL, Bushra T, Gunduz C

This study was undertaken to evaluate the expression of DMBT1 in bladder cancer and its correlation with clinico-pathological parameters analyzed in bladder carcinoma patients. We investigated DMBT1 in 56 paraffin embedded specimens of transitional c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3566::5b3f06422f39cce1da1c8620e49cd7be

The effect of the sun on expression of beta-catenin, p16 and cyclin d1

Autor: Demirkan, NC, Kesen, Z, Akdag, B, Larue, L, Delmas, V

Background. The tumour suppressor gene product, p16, is often inactivated during melanoma malignant progression. Although the importance of p16 in melanomas is well documented, its relationship with cyclin D1, beta-catenin and ultraviolet radiation (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3566::148bbbcb104e239b4fc8a8b4911c76ca
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/12206